Immunotherapy in Driver-Positive NSCLC

Podcast | English | 2024 | 47 Min

Create Account

Cost

$0.00

Credit

No Credit Offered

In this episode of Lung Cancer Considered, host Dr. Narjust Florez and two esteemed oncology colleagues discuss an evolving hot topic: the use of immune checkpoint inhibitors in the treatment of patients with molecular-driven non-small cell lung cancer.

Podcast Host:

Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and Thoracic Medical Oncologist, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School, Boston, MA, USA

Podcast Guests:

Biagio Ricciuti, MD, Thoracic Medical Oncologist and Data Scientist, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Erin Schenk, MD, Assistant Professor of Medicine in the Section of Medical Oncology, University of Colorado, Director of the Schenk Laboratory, Aurora, CO, USA